Human immunodeficiency virus type 1 Nef does not alter T-cell sensitivity to antigen-specific stimulation

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3776-3787

  Page, Kathleen A ^a,c   Van Schooten, Wim C A ^b   Feinberg, Mark B ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Activated Cell Therapy   (United States)

^c SOUTHERN OREGON UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; VIRUS PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; CELL CLONE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 0030978195     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3776-3787.1997     Document Type: Article

References (67)

1. Aiken, C., J. Konner, N. R. Landau, M. E. Lenburg, and D. Trono. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864.
2. Aiken, C., and D. Trono. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:5048-5056.
3. Anderson, S., D. C. Shugars, R. Swanstrom, and J. V. Garcia. 1993. Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J. Virol. 67:4923-4931.
4. Baur, A. S., E. T. Sawai, P. Dazin, W. J. Fanti, C. Cheng-Mayer, and B. M. Peterlin. 1994. HIV-1 nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373-384.
5. Bednarik, D. P., and T. M. Folks. 1992. Mechanisms of HIV-1 latency. AIDS 6:3-16.
6. Buelow, R., L. R. Pahorsky, W. C. van Schooten, T. J. Kummerehl, R. Schreifels, K. Marshall, J. Mayer, and J. B. Rothbard. 1993. Comparison of three different forms of HLA-DR4Dw4 proteins. Eur. J. Immunol. 23:69-76.
7. Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-427.
8. Buonaguro, L., G. Barillari, H. K. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66:7159-7167.
9. Carreer, R., H. Groux, J.-C. Ameisen, and A. Capron. 1994. Role of HIV-1 nef expression in activation pathways in CD4+ cells. AIDS Res. Hum. Retroviruses 10:523-527.
10. Chirmule, N., S. Than, S. A. Khan, and S. Pahwa. 1995. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J. Virol. 69:492-498.
11. Chowers, M. Y., C. A. Spina, T. J. Kwoh, N. J. S. Fitch, D. D. Richman, and J. C. Guatelli. 1994. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact neff gene. J. Virol. 68:2906-2914.
12. Collette, Y., H.-L. Chang, C. Cerdan, H. Chambost, M. Algarte, C. Mawas, J. Imbert, A. Burny, and D. Olive. 1996. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression. J. Immunol. 156:360-370.
13. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
14. Du, Z., S. M. Lang, V. G. Sasseville, A. A. Lackner, P. O. Ilyinskii, M. D. Daniel, J. U. Jung, and R. C. Desrosiers. 1995. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665-674.
15. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978.
16. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
17. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011-1018.
18. Feinberg, M. B., R. F. Jarrett, A. Aldovini, R. C. Gallo, and S. F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
19. Finzi, D., J. Margolick, K. Chadwick, D. Schwartz, and R. F. Siliciano. 1995. In vivo fate of HIV-1 infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1:1284-1290.
20. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kehrl, and A. S. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2368.
21. Folks, T. M., J. Justement, A. Kinter, C. A. Dinarello, and A. S. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238:800-802.
22. Garcia, J. V., and A. D. Miller. 1991. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350:508-511.
23. Goldsmith, M. A., M. T. Warmerdam, R. E. Atchison, M. D. Miller, and W. C. Greene. 1995. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69:4112-4120.
24. Greenway, A., A. Azad, and D. McPhee. 1995. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69:1842-1850.
25. Haanen, J. B. A. G., T. H. M. Ottenhoff, A. Voordouw, B. G. Elferink, P. R. Klatzer, H. Spits, and R. R. P. De Vries. 1986. HLA class II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells. Scand. J. Immunol. 23:101-108.
26. Hazan, U., D. Thomas, J. Alcami, F. Bachelerie, N. Israel, H. Yssel, J. L. Virelizier, and S. F. Arenzana. 1990. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription. Proc. Natl. Acad. Sci. USA 87:7861-7865.
27. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
28. Howcroft, T. K., K. Strebel, M. A. Martin, and D. S. Singer. 1993. Repression of MHC class I gene promoter by two-exon Tat of HIV. Science 260:1320-1322.
29. Kestler, H., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
30. Kirchhoff, F., T. C. Greenough, D. B. Grettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long term survivor with non progressive HIV-1 infection. N. Engl. J. Med. 332:228-238.
31. Li, C. J., D. J. Freidman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431.
32. Luo, T., and J. V. Garcia. 1996. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70:6493-6496.
33. Luria, S., I. Chambers, and P. Berg. 1991. Expression of the type 1 human immunodeficiency virus nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 88:5326-5330.
34. McCune, J. M. 1995. Viral latency in HIV disease. Cell 82:183-188.
35. Merrill, J. E., Y. Koyanagi, J. Zack, L. Thomas, F. Martin, and I. S. Chen. 1992. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J. Virol. 66:2217-2225.
36. Miller, M. D., M. B. Feinberg, and W. C. Greene. 1994. The HIV-1 nef gene acts as a positive viral infectivity factor. Trends Microbiol. 2:294-297.
37. Miller, M. D., M. T. Warmerdam, K. A. Page, M. B. Feinberg, and W. C. Greene. 1995. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69:579-584.
38. Miller, M. D., M. T. Warmerdam, I. Gaston, W. C. Greene, and M. B. Feinberg. 1994. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:101-113.
39. Mustafa, F., and H. L. Robinson. 1993. Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers. J. Virol. 67:6909-6915.
40. Niederman, T. M., J. V. Garcia, W. R. Hastings, S. Luria, and L. Ratner. 1992. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells. J. Virol. 66:6213-6219.
41. Niederman, T. M., W. R. Hastings, S. Luria, J. C. Bandres, and L. Ratner. 1993. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 194:338-344.
42. Nunn, M. F., and J. W. Marsh. 1996. Human immunodeficiency virus type 1 Ncf associates with a member of the p21-activated kinase family. J. Virol. 70:6157-6161.
43. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86: 2336-2340.
44. Page, K. A., N. R. Landau, and D. R. Littman. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
45. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
46. Perno, C. F., R. Yarchoan, D. A. Cooney, N. R. Hartman, D. S. Webb, Z. Hao, H. Mitsuya, D. G. Johns, and S. Broder. 1989. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J. Exp. Med. 169:933-951.
47. Purvis, S. F., D. L. Georges, T. M. Williams, and M. M. Lederman. 1992. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell. Immunol. 144:32-42.
48. Rhee, S. S., and J. W. Marsh. 1994. HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement. J. Immunol. 152:5128-5134.
49. Rogel, M. E., L. I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888.
50. Saksela, K., G. Cheng, and D. Baltimore. 1995. Proline-rich (PxxP) motifs in HIV-1 nef bind to SH3 domains of a subset of src kinases and are required for the enhanced growth of nef-viruses but not for the down-regulation of CD4. EMBO J. 14:484-491.
51. Sawai, E. T., A. Baur, H. Struble, B. M. Peterlin, J. A. Levy, and M. C. Cheng. 1994. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA 91:1539-1543.
52. Sawai, E. T., A. S. Baur, B. M. Peterlin, J. A. Levy, and M. C. Cheng. 1995. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270:15307-15314.
53. Scala, G., M. R. Ruocco, C. Ambrosino, M. Mallardo, V. Giordano, F. Baldassarre, E. Dragonetti, I. Quinto, and S. Venuta. 1994. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 Tat protein. J. Exp. Med. 179:961-971.
54. Schnittman, S. M., M. C. Psallidopoulos, H. C. Lane, L. Thompson, M. Baseler, F. Massari, C. H. Fox, N. P. Salzman, and A. S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305-308.
55. Schwartz, O., S. F. Arenzana, J. M. Heard, and O. Danos. 1992. Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4+ T cells expressing the nef protein. AIDS Res. Hum. Retroviruses 8:545-551.
56. Skowronski, J., D. Parks, and R. Mariani. 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:703-713.
57. Spina, C. A., T. J. Kwoh, M. Y. Chowers, J. C. Guatelli, and D. D. Richman. 1994. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179:115-123.
58. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1 infected individuals. J. Exp. Med. 182:1727-1737.
59. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
60. Trono, D. 1995. HIV accessory proteins: leading roles for the supporting cast. Cell 82:189-192.
61. van Schooten, W. C., J. L. Ko, N. van der Stope, J. B. Haanen, L. Pickering, R. R. deVries, and P. van den Elsen. 1992. T-cell receptor beta-chain gene usage in the T-cell recognition of Mycobacterium leprae antigens in one tuberculoid leprosy patient. Proc. Natl. Acad. Sci. USA 89:11244-11248.
62. Viscidi, R. P., K. Mayur, H. M. Lederman, and A. D. Frankel. 1989. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606-1608.
63. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
64. Westendorp, M. O., M. Li-Weber, R. W. Frank, and P. H. Krammer. 1994. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:4177-4185.
65. Westendorp, M. O., V. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Droge, and V. Lehmann. 1995. HIV-1 Tat potentiates TNF-induced NF-κB activation and TNF-mediated cytotoxicity by altering the cellular redox state. EMBO J. 14:546-554.
66. Westendorp, M. O., R. Frank, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P. H. Krammer. 1995. The mechanism of HIV-1 Tat and gp120-sensitized T cell apoptosis. Nature 375:497-500.
67. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.